| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.08B | 58.76B | 52.76B | 48.37B | 44.45B | 39.71B |
| Gross Profit | 11.84B | 11.44B | 10.34B | 9.64B | 8.70B | 7.20B |
| EBITDA | 6.80B | 6.88B | 6.22B | 5.44B | 5.33B | 4.42B |
| Net Income | 4.40B | 4.41B | 3.73B | 3.33B | 3.24B | 2.63B |
Balance Sheet | ||||||
| Total Assets | 42.62B | 43.34B | 39.71B | 33.64B | 33.14B | 30.34B |
| Cash, Cash Equivalents and Short-Term Investments | 15.01B | 16.15B | 15.79B | 11.79B | 12.80B | 11.50B |
| Total Debt | 1.69B | 1.72B | 2.39B | 1.03B | 1.57B | 1.92B |
| Total Liabilities | 11.82B | 12.52B | 12.03B | 9.19B | 11.00B | 10.86B |
| Stockholders Equity | 30.79B | 30.82B | 27.68B | 24.45B | 22.13B | 19.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.35B | 2.95B | 1.28B | 3.01B | 2.97B |
| Operating Cash Flow | 0.00 | 4.76B | 3.21B | 1.68B | 3.22B | 3.16B |
| Investing Cash Flow | 0.00 | -2.29B | 1.45B | -874.88M | -1.16B | -47.41M |
| Financing Cash Flow | 0.00 | -2.08B | -723.69M | -1.63B | -1.35B | -1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥56.96B | 14.56 | ― | 2.59% | 10.46% | 8.98% | |
73 Outperform | ¥50.52B | 15.40 | 17.50% | 3.14% | 5.62% | 3.81% | |
72 Outperform | ¥60.44B | 13.55 | 14.67% | 3.24% | 10.02% | 16.48% | |
72 Outperform | ¥39.60B | 17.13 | ― | 2.56% | 19.04% | 30.67% | |
71 Outperform | ¥78.29B | 12.19 | ― | 3.30% | 5.28% | 28.90% | |
68 Neutral | ¥37.08B | 10.83 | ― | 3.38% | -0.10% | -19.50% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |